194 related articles for article (PubMed ID: 7884417)
1. 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.
Saven A; Lemon RH; Kosty M; Beutler E; Piro LD
J Clin Oncol; 1995 Mar; 13(3):570-4. PubMed ID: 7884417
[TBL] [Abstract][Full Text] [Related]
2. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
O'Brien S; Kantarjian H; Estey E; Koller C; Robertson B; Beran M; Andreeff M; Pierce S; Keating M
N Engl J Med; 1994 Feb; 330(5):319-22. PubMed ID: 7904047
[TBL] [Abstract][Full Text] [Related]
4. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
5. 2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukaemia.
Delannoy A; Ferrant A; Martiat P; Montfort L; Doyen C; Sokal G; Michaux JL
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):311-5. PubMed ID: 7971251
[TBL] [Abstract][Full Text] [Related]
6. 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Robak T; Błoński JZ; Urbańska-Ryś H; Błasińska-Morawiec M; Skotnicki AB
Leukemia; 1999 Apr; 13(4):518-23. PubMed ID: 10214856
[TBL] [Abstract][Full Text] [Related]
7. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
8. Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.
Robak T; Błoński JZ; Kasznicki M; Góra-Tybor J; Dwilewicz-Trojaczek J; Stella-Hołowiecka B; Wołowiec D
Hematol J; 2002; 3(5):244-50. PubMed ID: 12391542
[TBL] [Abstract][Full Text] [Related]
9. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
Krykowski E; Warzocha K; Robak T
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
[TBL] [Abstract][Full Text] [Related]
10. Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.
Tallman MS; Hakimian D; Zanzig C; Hogan DK; Rademaker A; Rose E; Variakojis D
J Clin Oncol; 1995 Apr; 13(4):983-8. PubMed ID: 7707127
[TBL] [Abstract][Full Text] [Related]
11. High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
Juliusson G; Liliemark J
J Clin Oncol; 1993 Apr; 11(4):679-89. PubMed ID: 8097528
[TBL] [Abstract][Full Text] [Related]
12. 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis.
Zaucha JM; Hałaburda K; Ciepłuch H; Hellmann A
Acta Haematol Pol; 1994; 25(2):119-27. PubMed ID: 7915075
[TBL] [Abstract][Full Text] [Related]
13. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
Robak T; Bloński JZ; Kasznicki M; Blasińska-Morawiec M; Krykowski E; Dmoszyńska A; Mrugala-Spiewak H; Skotnicki AB; Nowak W; Konopka L; Ceglarek B; Maj S; Dwilewicz-Trojaczek J; Hellmann A; Urasiński I; Zdziarska B; Kotlarek-Haus S; Potoczek S; Grieb P
Blood; 2000 Oct; 96(8):2723-9. PubMed ID: 11023504
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
Byrd JC; Peterson B; Piro L; Saven A; Vardiman JW; Larson RA; Schiffer C
Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330
[TBL] [Abstract][Full Text] [Related]
15. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
[TBL] [Abstract][Full Text] [Related]
16. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ
Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235
[TBL] [Abstract][Full Text] [Related]
17. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
[TBL] [Abstract][Full Text] [Related]
18. Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.
Robak T; Boński JZ; Kasznicki M; Góra-Tybor J; Hellmann A; Konopka L; Dmoszyńska A; Dwilewicz-Trojaczek J; Wołowiec D;
Eur J Haematol; 2002 Jul; 69(1):27-36. PubMed ID: 12270059
[TBL] [Abstract][Full Text] [Related]
19. Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Blonski JZ; Robak T; Chojnowski K; Gora-Tybor J; Warzocha K; Ceglarek B; Seferynska I; Calbecka M; Kostyra A; Stella-Holowiecka B; Kloczko J; Dmoszynska A; Kowal M; Lewandowski K; Dwilewicz-Trojaczek J; Wiater E; Kuliczkowski K; Potoczek S; Hellmann A; Mital A; Skotnicki A; Nowak W; Sulek K; Zawilska K; Trelinski J
Eur J Haematol; 2013 Jul; 91(1):1-9. PubMed ID: 23521128
[TBL] [Abstract][Full Text] [Related]
20. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
